Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
Microvasc Res ; 140: 104310, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-34979154

RESUMO

Evidence suggests severe coronavirus disease-19 (COVID-19) infection is characterised by pulmonary and systemic microvasculature dysfunction, specifically, acute endothelial injury, hypercoagulation and increased capillary permeability. Diabetes, which is also characterised by vascular injury in itself, confers an increased risk of adverse COVID-19 outcomes. It has been suggested that pre-existing endothelial dysfunction and microvascular disease in diabetes will exacerbate the vascular insults associated with COVID-19 and thus lead to increased severity of COVID-19 infection. In this article, we evaluate the current evidence exploring the impact of microvascular complications, in the form of diabetic retinopathy and nephropathy, in individuals with COVID-19 and diabetes. Future insights gained from exploring the microvascular injury patterns and clinical outcomes may come to influence care delivery algorithms for either of these conditions.


Assuntos
COVID-19/fisiopatologia , Angiopatias Diabéticas/fisiopatologia , Endotélio Vascular/patologia , Microcirculação , Pandemias , SARS-CoV-2 , Trombofilia/etiologia , Albuminúria/etiologia , COVID-19/complicações , Permeabilidade Capilar , Atenção à Saúde , Angiopatias Diabéticas/complicações , Nefropatias Diabéticas/complicações , Nefropatias Diabéticas/fisiopatologia , Neuropatias Diabéticas/complicações , Neuropatias Diabéticas/fisiopatologia , Retinopatia Diabética/complicações , Retinopatia Diabética/fisiopatologia , Endotélio Vascular/lesões , Humanos , Obesidade/complicações , Obesidade/fisiopatologia , Circulação Pulmonar , Edema Pulmonar/etiologia , Edema Pulmonar/fisiopatologia , Índice de Gravidade de Doença , Trombofilia/fisiopatologia , Resultado do Tratamento
3.
Clin Ther ; 44(2): 323-330, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-34974945

RESUMO

PURPOSE: Diabetic foot ulcers (DFUs) and cardiac autonomic neuropathy (CAN) are severe complications of diabetes mellitus (DM). Both DFU and CAN are associated with increased risk of major cardiovascular events and mortality. Because of the clinical impact of both these conditions, it is important to establish what effect the presence of CAN has on DFU outcomes. METHODS: This is a narrative review of original research articles identified through an electronic search of PubMed, Scopus, and Google scholar databases until June 2021 exploring CAN in individuals with DFUs. We explored prevalence, patient outcomes (DFU healing and amputation), and mortality. FINDINGS: Evidence suggests that the prevalence of CAN is high, ranging from 43% to 66% among those with DFUs. The presence of CAN may also increase the odds of developing DFUs. A single-center, prospective, observational study has suggested that the presence of CAN significantly reduces DFU healing time. The impact on amputation is indeterminate, with conflicting reports from studies reporting either no or increased risk. On the basis of limited evidence, CAN may be associated with increased mortality in individuals with DFUs. IMPLICATIONS: The interplay between CAN and DFUs is poorly understood from current literature. Given the high prevalence of CAN in individuals with DFUs and the potential for suboptimal outcomes, further high-quality studies are required to determine future management approaches when both conditions coexist and to establish whether early CAN screening in individuals with diabetes at high risk of foot ulceration may ultimately improve their outlook.


Assuntos
Diabetes Mellitus , Pé Diabético , Doenças do Sistema Nervoso , Amputação Cirúrgica , Pé Diabético/diagnóstico , Pé Diabético/epidemiologia , Pé Diabético/terapia , Humanos , Estudos Observacionais como Assunto , Prevalência , Estudos Prospectivos , Cicatrização
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA